Brain abnormalities detected on whole-body 18F-FDG PET in cancer patients: spectrum of findings.
OBJECTIVE
The purpose of this article is to discuss and show examples of the PET appearance of common brain abnormalities that radiologists encounter when interpreting whole-body 18F-FDG PET examinations of cancer patients.


CONCLUSIONS
Knowledge of the PET appearance of various brain abnormalities can yield diagnostically relevant information in cancer patients. Detection of brain abnormalities on whole-body PET often requires adjusting window settings to reduce the intensity of normal brain FDG activity. Often, close correlation of PET/CT and MRI with clinical history offers the most complete radiologic diagnosis.
Stubbs
Erin
E
Department of Radiology, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157, USA.
Kraas
Jonathan
J
Morton
Kathryn A
KA
Clark
Paige B
PB
D001921:Brain / Q000000981:diagnostic imaging*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18